Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Shulan Pharmaceutical, primarily known as Jilin Shulan Synthetic Pharmaceutical Co., Ltd., is a leading Chinese manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and chemical intermediates. The company is recognized as one of the world's largest production bases for synthetic caffeine, supplying major global beverage and pharmaceutical brands. In addition to caffeine, its product portfolio includes theophylline, aminophylline, and various chemical raw materials. The company operates high-capacity manufacturing facilities that comply with international GMP standards and is a major exporter to markets in Europe, the Americas, and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Shulan Pharmaceutical.